New therapeutic targets for the treatment of high-risk neuroblastoma.
about
NeuroblastomaExtracellular MicroRNA in liquid biopsy: applicability in cancer diagnosis and preventionNeuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosisInhibition of neuroblastoma tumor growth by targeted delivery of microRNA-34a using anti-disialoganglioside GD2 coated nanoparticlesNuclear GRP75 binds retinoic acid receptors to promote neuronal differentiation of neuroblastomaCDK Inhibitors Roscovitine and CR8 Trigger Mcl-1 Down-Regulation and Apoptotic Cell Death in Neuroblastoma CellsTolcapone induces oxidative stress leading to apoptosis and inhibition of tumor growth in Neuroblastoma.Enhanced anti-tumor activity of a new curcumin-related compound against melanoma and neuroblastoma cellsMyc proteins as therapeutic targets.Targeting Notch pathway induces growth inhibition and differentiation of neuroblastoma cells.Expressional alterations in functional ultra-conserved non-coding RNAs in response to all-trans retinoic acid--induced differentiation in neuroblastoma cells.Silencing of doublecortin-like (DCL) results in decreased mitochondrial activity and delayed neuroblastoma tumor growth.Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings.Pharmacologic management of high-risk neuroblastoma in childrenp73 in Cancer.Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma.Honokiol traverses the blood-brain barrier and induces apoptosis of neuroblastoma cells via an intrinsic bax-mitochondrion-cytochrome c-caspase protease pathway.MYCN repression of Lifeguard/FAIM2 enhances neuroblastoma aggressivenessEfficient Killing of High Risk Neuroblastoma Using Natural Killer Cells Activated by Plasmacytoid Dendritic Cells.Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma.A practical, automated synthesis of meta-[(18)F]fluorobenzylguanidine for clinical use.Notch ligand Delta-like 1 as a novel molecular target in childhood neuroblastomaMicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes.Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma.p53 family: Therapeutic targets in neuroblastoma.Pharmacotherapy of neuroblastoma.Therapeutic targeting of miRNAs in neuroblastoma.The connections between neural crest development and neuroblastoma.Practical implications for the administration of 13-cis retinoic acid in pediatric oncology.Retinoids: novel immunomodulators and tumour-suppressive agents?MicroRNA mediates DNA demethylation events triggered by retinoic acid during neuroblastoma cell differentiationAction of HMGB1 on miR-221/222 cluster in neuroblastoma cell lines.Omega-3 Polyunsaturated Fatty Acids Trigger Cell Cycle Arrest and Induce Apoptosis in Human Neuroblastoma LA-N-1 Cells.Novel Platinum(II) compounds modulate insulin-degrading enzyme activity and induce cell death in neuroblastoma cells.Deubiquitinating activity of CYLD is impaired by SUMOylation in neuroblastoma cells.Synergistic effects of combination treatment with bortezomib and doxorubicin in human neuroblastoma cell lines.Quercetin-mediated synthesis of graphene oxide-silver nanoparticle nanocomposites: a suitable alternative nanotherapy for neuroblastoma.Botulinum neurotoxin type C protease induces apoptosis in differentiated human neuroblastoma cells.N-Myc overexpression increases cisplatin resistance in neuroblastoma via deregulation of mitochondrial dynamics.The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy.
P2860
Q24617733-A68C0BD8-15CB-499A-A347-18D1CB1F6327Q26742027-3CF5D358-7A3B-4C44-B501-DD0F4DED643AQ26774960-31FC3D72-0AC9-4D54-B8CD-46E059E315FFQ27301841-043CAC23-26ED-4223-9228-79D523451064Q27316571-64D15A25-6702-47D3-A5EF-993B351B3967Q27670943-D291E7B1-7129-445A-B7EE-8864E1624F7BQ33775239-66C67DA7-E73F-4DDF-92D0-10B5F905AAD6Q33968452-698C03BD-ACB3-47A7-9630-F8F72068B9B1Q33997741-712F5BB8-9136-452A-B440-E0B4FA288F4EQ34480664-719D462B-10A8-4607-84D4-4720B2A5F8B9Q34658931-BB3C8D7D-17B7-4B45-9313-2C6F9937302AQ35005945-EBA6E11D-8F93-4418-986B-B2E4C0576188Q35049970-747BFFAA-E72F-4EBE-9B5B-CD3B1392507BQ35064095-7ED1C0D9-4565-4001-A41F-E48A5F2C4C3FQ35103143-39D4FDA6-01FC-496B-A4A5-265C6A576807Q35755392-D165FEFF-940E-4630-93E1-D6DC46C3E73BQ35760648-6CFB935E-0F47-4536-A6D9-DA0B9344806DQ35966204-5B38FA22-8E72-4277-A07A-FE0AB2B8555BQ36157777-1057B158-A617-4BBA-8AA2-4119E56C7D37Q36243746-A1EF9601-8160-4975-AEC7-8996800784BBQ36296809-7553ED22-4B91-4402-9A93-E41B38802312Q36376636-63FB8877-5B3A-4080-9E04-8B0157285191Q36962575-5E387071-EF82-4D84-BB83-6555382324A6Q37475389-0FC58FCE-5863-4855-ACB0-9EBE6E662672Q37707387-53F3AD99-5F62-4A12-B2DD-995A610B10F0Q37735199-4DF75232-5A66-4531-A578-2F47DBADF15FQ37775637-1FF6ACE9-B91C-42BA-8D75-9972B5077C62Q37836006-6FA695F0-09AF-4C5D-9969-F055F32050A0Q37872230-79DF0606-47D4-4C23-9902-02F16A1ED296Q38009350-A17C9216-A565-4DE6-BC3B-AE179CA615A5Q38505096-A68D84B1-3793-47C8-9202-E66377C9F7A9Q38747810-201084C3-AA29-4793-8367-19E178113920Q38842035-EEB2DF26-DB80-45F7-85D5-6616E0FDB73AQ38934781-C1835D97-B4F7-42C6-B008-77E026C69DACQ38987154-A9D8134F-E525-45E8-9C66-A4F4DDF8CF3CQ39397750-E9155B79-3095-48C0-BDC3-00E153B01126Q40071681-1F4CFCCC-FEA2-4BDF-813C-B51A34E6AA83Q41561905-457DAD6D-723F-4E9B-8457-6742F50BAA5EQ41857674-E64B0C58-1A7E-44C8-95B7-38CC28DAA545Q42089520-8F3AF844-FA04-4040-8492-23C1B5BFBD70
P2860
New therapeutic targets for the treatment of high-risk neuroblastoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New therapeutic targets for the treatment of high-risk neuroblastoma.
@en
New therapeutic targets for the treatment of high-risk neuroblastoma.
@nl
type
label
New therapeutic targets for the treatment of high-risk neuroblastoma.
@en
New therapeutic targets for the treatment of high-risk neuroblastoma.
@nl
prefLabel
New therapeutic targets for the treatment of high-risk neuroblastoma.
@en
New therapeutic targets for the treatment of high-risk neuroblastoma.
@nl
P2860
P356
P1476
New therapeutic targets for the treatment of high-risk neuroblastoma.
@en
P2093
Lars M Wagner
Mary K Danks
P2860
P356
10.1002/JCB.22094
P577
2009-05-01T00:00:00Z